Vigilant gets CE Mark for oral cancer test

DrBicuspid.com staff writers
Nov 15, 2015

Vigilant Biosciences' OncAlert oral cancer CD44/total protein lab test has received the CE Mark, which allows the company to market the test in Europe.

The test can now be sold in the 28 countries of the European Union, as well as Norway, Iceland, Liechtenstein, and Switzerland. The OncAlert system is not available in the U.S. at this time, the company said.

The assay detects a tumor-initiating stem cell biomarker for head and neck cancer, Vigilant said. It measures soluble CD44 and total protein levels -- specific protein markers known to indicate early-stage cancers -- in an oral rinse.

Latest in Oral Cancer
Bill Brodie
Cellerant CEO series: Vigilant Biosciences and advances in the battle against oral cancer
April 18, 2024
Do you have patients who can’t or simply won’t floss?
Sponsored
Do you have patients who can’t or simply won’t floss?
February 2, 2024
Dr. Aaron Weinberg, PhD. Image courtesy of Case Western University.
New test may be better way to detect oral cancer
March 26, 2024
Cancer Cell
Oral cancer detection with a stroke of a brush?
January 30, 2024
Related Stories
2013 04 10 10 14 48 506 Cancer Cell 200
Oral Cancer
Developer of oral cancer testing system motivated by parents' disease
2013 09 03 14 41 25 490 Hpv 200
Oral Cancer
ASTRO: HPV+ patients don't need high treatment doses
2013 06 20 16 42 16 777 Sound Wave 200
Oral Cancer
ASTRO: New ultrasound gene therapy may treat xerostomia
Do you have patients who can’t or simply won’t floss?
Sponsor Content
Do you have patients who can’t or simply won’t floss?
More in Oral Cancer
Cellerant CEO series: Vigilant Biosciences and advances in the battle against oral cancer
By Kevin Henry
As Oral Cancer Awareness Month continues, we take a look at a company that is using biomarkers as a way to catch oral cancer earlier and give patients a better chance of survival.
April 18, 2024
Bill Brodie
Nanoparticles to be developed to treat oral cancer
By Ava Barros
A lipid nanoparticles platform may treat oral squamous cell carcinoma by changing the genetic material of lymph nodes, according to research presented at the International Association for Dental, Oral, and Craniofacial Research.
April 1, 2024
Researcher
New test may be better way to detect oral cancer
By Ava Barros
A new test may detect a germ-fighting protein associated with oral cancer, track precancerous lesions, and determine when a biopsy is necessary. The study was recently published in Cell Reports Medicine.
March 26, 2024
Dr. Aaron Weinberg, PhD. Image courtesy of Case Western University.
Oral cancer detection with a stroke of a brush?
By Ava Barros
Researchers at the University of Illinois at Chicago College of Dentistry have created a diagnostic test kit that detects oral cancer early with a brush biopsy that can be done in a dental office, according to an article published by the university.
January 30, 2024
Cancer Cell
It’s not cheesy. An antimicrobial may treat oral cancer.
By Ava Barros
Researchers are conducting a clinical trial to determine whether an antimicrobial food additive found in cheese may be used to treat oral cell carcinoma, according to the University of California, Los Angeles School of Dentistry.
January 29, 2024
Bacteria Microscope
This numbing agent may kill HNC cells
By Ava Barros
The common dental numbing agent lidocaine triggers specific bitter taste receptors in the mouth that may ultimately lead to the death of head and neck cancer cells, according to a preclinical study recently published in Cell Reports.
December 5, 2023
Anesthetic Needle Vials
Young users of e-cigarettes more likely to report chronic stress
By Amerigo Allegretto
Young people who vape are more than twice as likely to report experiencing chronic stress.
October 3, 2023
Vaping Teenager
'Gates of heaven' calcium channel may drive oral cancer growth, pain
By Will Morton
New York University researchers suggest that ORAI1 calcium channel activity in oral cancer cells could be targeted to reduce the growth of oral tumors and reduce pain, according to a study that was recently published in Science Signaling.
September 12, 2023
Cell Gene Therapy Dna
MUSC researchers developing oral cancer vaccine
By Amerigo Allegretto
Researchers from the Medical University of South Carolina (MUSC) are developing a new type of personalized vaccine to prevent recurrences of oral cancer.
September 7, 2023
Researcher
Researchers awarded grant to study radiation therapy delays
By Amerigo Allegretto
Researchers from South Carolina have been awarded a $3.5 million grant to reduce delays in radiation therapy for head and neck cancers.
August 28, 2023
Radiation Therapy
Raising awareness of oral cancer through patient communication
By Misty Mattingly, RDH
With increasing rates of oral cancer, it’s time to re-examine our approach to informing patients about the risks, writes Misty Mattingly, RDH.
August 24, 2023
Misty Mattingly, RDH.
High oral HPV burden puts older men at risk of oropharyngeal cancer
By Kate Madden Yee
Older men carry the highest burden of oral HPV, putting them at the greatest of oropharyngeal cancer.
August 22, 2023
Male Patient Dental Chair
Page 1 of 115
Next Page